Serigen Mediproducts Secures INR 10 crores Funding led by IAN Alpha Fund & others – Medgate Today
Summary
Pune based, Serigen Mediproducts, a unique biomedical products manufacturing company has raised INR 10 crores from IAN Alpha Fund & Colossa Ventures, along with existing and new angel investors. Serigen Mediproducts is also a part of BioAngels portfolio company, which aligns with their vision of advancing biotechnology innovations.Serigen is at the forefront of developing tissue regeneration products using silk proteins. Their innovative approach to leveraging silk proteins for critical care solutions aligns with our mission to back women-led ventures that are poised for scalable growth and can also drive meaningful impact. The company is certified under international quality standard ISO 13485 and has already secured CDSCOs (Indian regulator) approvals for manufacturing and sales of its advanced wound care product Seriderm\xae.IAN Alpha Fund, a Rs. The Fund will explore opportunities in diverse sectors such as fintech, healthtech, renewable energy, deep tech, agritech, medtech, hardware and electronics, manufacturing, Web 3.0, Metaverse, Industry 4.0, SaaS, D2C, and other domains where innovation abounds.